title: Novel hemagglutinin-based influenza virus inhibitors.
abstract: Influenza virus has caused seasonal epidemics and worldwide pandemics, which caused tremendous loss of human lives and socioeconomics. Nowadays, only two classes of anti-influenza drugs, M2 ion channel inhibitors and neuraminidase inhibitors respectively, are used for prophylaxis and treatment of influenza virus infection. Unfortunately, influenza virus strains resistant to one or all of those drugs emerge frequently. Hemagglutinin (HA), the glycoprotein in influenza virus envelope, plays a critical role in viral binding, fusion and entry processes. Therefore, HA is a promising target for developing anti-influenza drugs, which block the initial entry step of viral life cycle. Here we reviewed recent understanding of conformational changes of HA in protein folding and fusion processes, and the discovery of HA-based influenza entry inhibitors, which may provide more choices for preventing and controlling potential pandemics caused by multi-resistant influenza viruses.
authors: School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; ; Department of Physiology, Huaihua Medical College, Huaihua 418000, China.
authors: Xintian
authors: X
authors: Shen
authors: Xuanxuan
authors: X
authors: Zhang
authors: Shuwen
authors: S
authors: Liu
keywords: Hemagglutinin (HA); antiviral drugs; influenza virus; viral entry
references: Curr Med Chem. 2007;14(21):2304-13
references: 17896978
references: Nature. 1981 Jan 29;289(5796):366-73
references: 7464906
references: Antimicrob Agents Chemother. 2006 Apr;50(4):1470-9
references: 16569867
references: Science. 2009 Apr 10;324(5924):246-51
references: 19251591
references: J Virol. 2007 Sep;81(18):9950-5
references: 17626098
references: Virology. 1998 Sep 1;248(2):264-74
references: 9721235
references: N Engl J Med. 2003 May 29;348(22):2228-38
references: 12773651
references: Virology. 1999 May 25;258(1):1-20
references: 10329563
references: J Virol. 2010 May;84(10):5089-96
references: 20219906
references: FEBS Lett. 1993 May 10;322(2):115-9
references: 8387030
references: Lancet. 2004 Aug 28-Sep 3;364(9436):759-65
references: 15337401
references: J Virol. 1997 May;71(5):4062-70
references: 9094684
references: Science. 2013 Jun 21;340(6139):1459-63
references: 23641061
references: Antiviral Res. 2009 Feb;81(2):132-40
references: 19028526
references: Science. 2007 Feb 2;315(5812):655-9
references: 17272724
references: N Engl J Med. 2013 May 16;368(20):1888-97
references: 23577628
references: J Antibiot (Tokyo). 2002 Feb;55(2):165-71
references: 12002998
references: Biochemistry. 1993 Mar 30;32(12):2967-78
references: 8457561
references: Antiviral Res. 2005 Nov;68(2):66-74
references: 16137775
references: Protein Cell. 2010 Apr;1(4):342-354
references: 21203946
references: Influenza Other Respir Viruses. 2007 Sep-Nov;1(5-6):189-92
references: 19453426
references: PLoS One. 2009 Nov 06;4(11):e7838
references: 19893749
references: Phytochemistry. 2009 Jul;70(10):1255-61
references: 19682714
references: Virology. 1996 Dec 1;226(1):66-76
references: 8941323
references: Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21
references: 21825125
references: J Virol. 2011 Nov;85(21):11048-57
references: 21865387
references: Arch Virol. 2003 Mar;148(3):469-86
references: 12607099
references: Nature. 2012 Sep 27;489(7417):526-32
references: 22982990
references: J Biol Chem. 2011 Dec 9;286(49):42141-42149
references: 21994935
references: Eur J Med Chem. 2012 Nov;57:211-6
references: 23059548
references: Science. 2006 Apr 21;312(5772):404-10
references: 16543414
references: J Gen Virol. 2007 Mar;88(Pt 3):951-955
references: 17325369
references: J Virol. 2006 Dec;80(24):11960-7
references: 17005658
references: Yonsei Med J. 2012 Sep;53(5):886-93
references: 22869469
references: Antimicrob Agents Chemother. 1992 Jul;36(7):1432-6
references: 1510439
references: Curr Top Microbiol Immunol. 1992;176:119-30
references: 1600749
references: Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7
references: 21536025
references: Cell Res. 2013 Feb;23(2):300-2
references: 23208422
references: Biol Pharm Bull. 2009 Aug;32(8):1385-91
references: 19652378
references: Arch Virol. 1999;144(5):865-78
references: 10416371
references: J Biochem. 1997 Feb;121(2):309-16
references: 9089405
references: PLoS One. 2012;7(8):e41956
references: 22876294
references: Virology. 2013 Jan 20;435(2):320-8
references: 23084424
references: Int J Biol Sci. 2009 Aug 08;5(6):543-8
references: 19680476
references: J Med Chem. 2010 Jun 10;53(11):4441-9
references: 20476787
references: J Med Chem. 2009 Jul 23;52(14):4247-56
references: 19558186
references: Nature. 2012 May 02;486(7403):420-8
references: 22722205
references: Adv Exp Med Biol. 2012;726:201-21
references: 22297515
references: Nat Prod Rep. 2010 Jan;27(12):1758-80
references: 20941447
references: Microbiol Immunol. 2000;44(8):677-85
references: 11021398
references: Nat Rev Genet. 2008 Apr;9(4):267-76
references: 18319742
references: Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41
references: 19004788
references: Virology. 2008 Jan 20;370(2):403-14
references: 17936324
references: Lancet Infect Dis. 2011 Sep;11(9):677-83
references: 21550310
references: Eur J Cardiothorac Surg. 2009 Nov;36(5):869-75
references: 19782574
references: ACS Med Chem Lett. 2011 Jun 07;2(8):603-7
references: 24900355
references: Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226-49
references: 22728439
references: Science. 2009 Jul 24;325(5939):484-7
references: 19574347
references: J Virol. 1999 Jan;73(1):140-51
references: 9847316
references: Annu Rev Biochem. 2000;69:531-69
references: 10966468
references: Curr Med Chem. 2008;15(10):997-1005
references: 18393857
references: J Biol Chem. 1992 Jul 5;267(19):13573-9
references: 1618859
references: Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
references: 22371588
references: J Virol. 1997 Nov;71(11):8808-20
references: 9343241